Citation: T. Grodzicki et al., AGING AND ESSENTIAL-HYPERTENSION - EFFECT OF LEFT-VENTRICULAR HYPERTROPHY ON CARDIAC-FUNCTION, American journal of hypertension, 11(4), 1998, pp. 425-429
Authors:
NUNEZ E
NUNEZ JE
MICHALEWICZ L
MESSERLI FH
Citation: E. Nunez et al., GENDER DIFFERENCES IN HYPERTENSIVE TARGET ORGAN DISEASE, Journal of the American College of Cardiology, 31(2), 1998, pp. 522-522
Citation: Fh. Messerli et L. Michalewicz, FIXED DRUG-COMBINATIONS IN THE TREATMENT OF HYPERTENSION - HOW TO IDENTIFY THE OPTIMAL DOSE, Journal of hypertension, 16, 1998, pp. 81-84
Authors:
KETELHUT RG
MESSERLI FH
LOSEM C
FROHLICH ED
MICHALEWICZ L
Citation: Rg. Ketelhut et al., SYSTEMIC AND REGIONAL HEMODYNAMIC-EFFECTS OF GALLOPAMIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Cardiovascular drugs and therapy, 11(1), 1997, pp. 39-42
Citation: Fh. Messerli et al., COMBINATION THERAPY AND TARGET ORGAN PROTECTION IN HYPERTENSION AND DIABETES-MELLITUS, American journal of hypertension, 10(9), 1997, pp. 198-201
Citation: L. Michalewicz, PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE END-POINTS USING BETA-BLOCKERS (VOL 277, PG 1759, 1997), JAMA, the journal of the American Medical Association, 278(11), 1997, pp. 900-900
Authors:
AEPFELBACHER FC
MESSERLI FH
NUNEZ E
MICHALEWICZ L
Citation: Fc. Aepfelbacher et al., CARDIOVASCULAR EFFECTS OF A TRANDOLAPRIL VERAPAMIL COMBINATION IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION/, The American journal of cardiology, 79(6), 1997, pp. 826
Citation: L. Michalewicz et Fh. Messerli, CARDIAC EFFECTS OF CALCIUM-ANTAGONISTS IN SYSTEMIC HYPERTENSION, The American journal of cardiology, 79, 1997, pp. 39-46
Citation: Fh. Messerli et L. Michalewicz, SAFETY OF HEART RATE-LOWERING CALCIUM-ANTAGONISTS - LESSONS FROM CONTROLLED TRIALS, The American heart journal, 134(2), 1997, pp. 21-24